glp-1 agonists drugs Market Overview: and the Obesity Market | Blog GLP-1 Receptor Agonists and Research

Long acting amylin receptor agonist, AZD6234, shows advantages over GLP-1 receptor agonist activation for leptin re-sensitization in a diet-induced obese (DIO) rat model

However, the elevated point estimate and wide confidence interval meant that a clinically significant increase could not be excluded

Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high-frequency or chronic migraine: a prospective pilot study

Trinh TA, Le TMD, Nguyen HTT, Nguyen TL, Kim J, Huynh DP, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 354.Rinaman L

Discussion Endothelial dysfunction can be considered as a valuable biomarker for predicting atherosclerosis and other cardiovascular lesions 10